Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday - Amgen (NASDAQ:AMGN)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Piper Sandler boosted Itron, Inc. (NASDAQ:ITRI) price target from $72 to $91. Piper Sandler analyst Kashy Harrison upgraded the stock from Neutral to Overweight. Itron shares rose 0.01% to close at $73.02 on Monday. See how other analysts view this stock.
HC Wainwright & Co. cut the price target for Cara Therapeutics, Inc. (NASDAQ:CARA) from $7 to $2.5. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. Cara Therapeutics shares fell 48.9% to close at $0.6291 on Monday. See how other analysts view this stock.
JP Morgan cut the price target for PepsiCo, Inc. (NASDAQ:PEP) from $185 to $176. JP Morgan analyst Andrea Teixeira downgraded the stock from Overweight to Neutral. PepsiCo shares gained 1.1% to close at $168.91 on Monday. See how other analysts view this stock.
BMO Capital increased the price target for Amgen Inc. (NASDAQ:AMGN) from $286 to $326. BMO Capital analyst Evan David Seigerman upgraded the stock from Market Perform to Outperform. Amgen shares rose 0.01% to close at $275.48 on Monday. See how other analysts view this stock.
Stifel cut the price target for Vertex Energy, Inc. (NASDAQ:VTNR) from $ $6 to $4. Stifel analyst Michael Hoffman downgraded the stock from Buy to Hold. Vertex Energy shares gained 6.1% to close at $3.64 on Monday. See how other analysts view this stock.
Keybanc boosted Uber Technologies, Inc. (NYSE:UBER) price target from $61 to $70. Keybanc analyst Justin Patterson maintained an Overweight rating. Uber shares fell 0.2% to close at $61.73 on Monday. See how other analysts view this stock.
Raymond James cut Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) price target from $78 to $64. Raymond James analyst Steven Seedhouse maintained a Strong Buy rating. Mirum Pharmaceuticals shares fell 15.9% to close at $29.39 on Monday. See how other analysts view this stock.
HC Wainwright & Co. cut Kronos Bio, Inc. (NASDAQ:KRON) price target from $9 to $2.5. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. Kronos Bio shares fell 2% to close at $1.46 on Monday. See how other analysts view this stock.
Piper Sandler raised Sunrun Inc. (NASDAQ:RUN) price target from $15 to $31. Piper Sandler analyst Kashy Harrison upgraded the stock from Neutral to Overweight. Sunrun shares fell 3.2% to close at $18.03 on Monday. See how other analysts view this stock.
Baird cut Masonite International Corporation (NYSE:DOOR) price target from $106 to $92. Baird analyst Timothy Wojs downgraded the stock from Outperform to Neutral. Masonite International shares fell 16% to close at $85.71 on Monday. See how other analysts view this stock.

Check This Out: Accenture, FactSet Research And 3 Stocks To Watch Heading Into Tuesday

MIRMMirum Pharmaceuticals Inc

UBERUber Technologies Inc

$70.61-1.66%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.